BIA ‘Reassured’ On Post-Brexit SPC Regime But Data Exclusivity Concerns Remain
Executive Summary
The government has said it is prepared to discuss the terms of supplementary protection certificates under a UK-only regime if there is a no-deal Brexit, but concerns also linger over the start dates for regulatory data protection.
You may also be interested in...
UK Govt Has ‘Made A Hash’ Of Managing Brexit For Life Sciences Sector
A recent debate in the House of Lords saw some fiery words exchanged over the government’s plans for the life science sector in the event of a no-deal Brexit, with accusations that they would produce a “clunky” regulatory system and put industry’s future “at grave risk.”
UK Industry Skeptical Of Govt’s No-Deal Brexit Filing Expectations
The BioIndustry Association’s latest Brexit webinar looked at issues such as companies’ drug filing strategies in a no-deal scenario as well as the costs that industry is likely to incur as a result of changes to regulatory processes.
Two-Year Stockpiling Provision ‘Vastly Improves’ European SPC Waiver
The latest vote from the European Parliament’s legal committee has been praised by industry for allowing firms to stockpile for two years ahead of SPC expiry to prepare for a ‘day one’ launch.